- Report
- August 2025
- 195 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- August 2025
- 367 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- February 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Report
- May 2025
- 300 Pages
Global
From €3546EUR$3,995USD£3,052GBP
- Report
- May 2025
- 184 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- November 2024
- 171 Pages
Global
From €5281EUR$5,950USD£4,545GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- August 2025
- 127 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2024
- 142 Pages
Global
From €2662EUR$2,999USD£2,291GBP
- Report
- February 2024
- 117 Pages
Global
From €4216EUR$4,750USD£3,629GBP
- Report
- April 2023
- 115 Pages
Global
From €4216EUR$4,750USD£3,629GBP

The Diagnostic Antibodies market is a subset of the Diagnostics industry, which focuses on the development and production of antibodies used to detect and diagnose diseases. Diagnostic antibodies are used to detect the presence of a specific antigen in a sample, such as a blood or tissue sample. These antibodies are used to diagnose a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Diagnostic antibodies are also used to monitor the progression of a disease or to measure the effectiveness of a treatment.
The Diagnostic Antibodies market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and Roche. Show Less Read more